112 related articles for article (PubMed ID: 25434307)
1. Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma.
Guo XF; Yang ZR; Wang J; Lei XF; Lv XG; Dong WG
Mol Med Rep; 2015 Apr; 11(4):2562-8. PubMed ID: 25434307
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of puerarin combined with 5-fluorouracil on esophageal cancer.
Wang J; Yang ZR; Guo XF; Song J; Zhang JX; Wang J; Dong WG
Mol Med Rep; 2014 Nov; 10(5):2535-41. PubMed ID: 25189132
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells.
Zhou XX; Ji F; Zhao JL; Cheng LF; Xu CF
J Gastroenterol Hepatol; 2010 Jul; 25(7):1266-75. PubMed ID: 20594254
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.
Tang XY; Zhu YQ; Tao WH; Wei B; Lin XL
Postgrad Med J; 2007 May; 83(979):338-43. PubMed ID: 17488865
[TBL] [Abstract][Full Text] [Related]
5. EBP50 gene transfection promotes 5-fluorouracil-induced apoptosis in gastric cancer cells through Bax- and Bcl-2-triggered mitochondrial pathways.
Lv XG; Ji MY; Dong WG; Lei XF; Liu M; Guo XF; Wang J; Fang C
Mol Med Rep; 2012 May; 5(5):1220-6. PubMed ID: 22366766
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil.
Liu J; Li X; Cheng YN; Cui SX; Chen MH; Xu WF; Tian ZG; Makuuchi M; Tang W; Qu XJ
Eur J Pharmacol; 2007 Nov; 574(1):1-7. PubMed ID: 17904544
[TBL] [Abstract][Full Text] [Related]
7. Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: implication in oxidative stress.
Matsunaga T; Tsuji Y; Kaai K; Kohno S; Hirayama R; Alpers DH; Komoda T; Hara A
Cancer Chemother Pharmacol; 2010 Aug; 66(3):517-26. PubMed ID: 19967538
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis.
Yuan F; Shi H; Ji J; Cai Q; Chen X; Yu Y; Liu B; Zhu Z; Zhang J
Oncol Rep; 2015 Apr; 33(4):1753-62. PubMed ID: 25634241
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma.
Wang J; Liu W; Zhao Q; Qi Q; Lu N; Yang Y; Nei FF; Rong JJ; You QD; Guo QL
Toxicology; 2009 Feb; 256(1-2):135-40. PubMed ID: 19084572
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
Shi M; Lou B; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice.
Wu DD; Xiao YF; Geng Y; Hou J
Cancer Genet Cytogenet; 2010 Apr; 198(2):90-6. PubMed ID: 20362223
[TBL] [Abstract][Full Text] [Related]
12. [Study of the anti-tumor effect of anti-vascular endothelial growth factor McAb 5-fluorouracil loaded polylactic acid nanoparticles].
Huang KH; Liu JH; Wang LY; Zhu ZH; Chen QK; Min J; Chen RF
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):482-5. PubMed ID: 17851795
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer.
Kim SL; Kim SH; Trang KT; Kim IH; Lee SO; Lee ST; Kim DG; Kang SB; Kim SW
Cancer Lett; 2013 Jul; 335(2):479-86. PubMed ID: 23507557
[TBL] [Abstract][Full Text] [Related]
14. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
[TBL] [Abstract][Full Text] [Related]
15. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
[TBL] [Abstract][Full Text] [Related]
16. Luteolin synergizes the antitumor effects of 5-fluorouracil against human hepatocellular carcinoma cells through apoptosis induction and metabolism.
Xu H; Yang T; Liu X; Tian Y; Chen X; Yuan R; Su S; Lin X; Du G
Life Sci; 2016 Jan; 144():138-47. PubMed ID: 26656468
[TBL] [Abstract][Full Text] [Related]
17. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
Ji YB; Zhou JH; Zuo MX; You QD
Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effect of sinomenine combined with 5-fluorouracil on colon carcinoma cell growth.
Zhang JX; Yang ZR; Wu DD; Song J; Guo XF; Wang J; Dong WG
Asian Pac J Cancer Prev; 2014; 15(16):6737-43. PubMed ID: 25169518
[TBL] [Abstract][Full Text] [Related]
19. Effects of 5‑fluorouracil and class III phosphoinositide 3‑kinase small interfering RNA combination therapy on SGC7901 human gastric cancer cells.
Zhu BS; Sun JL; Gong W; Zhang XD; Wu YY; Xing CG
Mol Med Rep; 2015 Mar; 11(3):1891-8. PubMed ID: 25385552
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of puerarin and 5-fluorouracil on hepatocellular carcinoma.
Zeng YP; Yang ZR; Guo XF; Jun W; Dong WG
Oncol Lett; 2014 Dec; 8(6):2436-2442. PubMed ID: 25364405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
